hemoglobin A1C (HbA1c)
A measure of average blood glucose over the preceding 2-3 months, calculated as the percentage of hemoglobin molecules bound to glucose. A diagnostic marker for diabetes (>6.5% = diabetes; 5.7-6.4% = prediabetes) and a predictor of all-cause mortality even in non-diabetics.
As defined in Outlive: The Science and Art of Longevity — Dr. Peter Attia
Other definitions
Form of hemoglobin that has glucose covalently bound to it through glycation; reflects average blood glucose levels over 2-3 months; used as a diagnostic marker for diabetes
The Subcellular Processes That Belie All Chronic Disease. The Hateful (or Grateful) Eight #lustig
Where it comes up · 2
- Outlive: The Science and Art of Longevity — Dr. Peter Attia3 claims
- The Subcellular Processes That Belie All Chronic Disease. The Hateful (or Grateful) Eight #lustig2 claims
Most important claims · 5 of 5Search all claims for “hemoglobin A1C (HbA1c)” →
- In a non-diabetic population, there is a dose-dependent relationship where lower average blood glucose (estimated by hemoglobin A1C) correlates with lower all-cause mortality; a person with A1C of 5.0 (average glucose ~100 mg/dL) has better outcomes than a person with A1C of 6.0 (~120 mg/dL), despite both being non-diabetic.Outlive: The Science and Art of Longevity — Dr. Peter Attia
- Hemoglobin A1C is an imperfect measure of kidney function because it varies based on red blood cell turnover rate; creatinine (the conventional kidney function marker) is equally flawed, overestimating kidney function in people with low muscle mass and underestimating it in people with high muscle mass or recent exercise.Outlive: The Science and Art of Longevity — Dr. Peter Attia
- Glycation (non-enzymatic glycation of proteins) occurs through the Maillard reaction when glucose binds to the epsilon amino group of lysine, forming a Schiff base that spontaneously decomposes into an irreversible amidori rearrangement; this is the same browning process that occurs in food at high heat and occurs in the body at 98.6°F over 75 yearsThe Subcellular Processes That Belie All Chronic Disease. The Hateful (or Grateful) Eight #lustig
- Five major randomized controlled trials show that lowering hemoglobin A1C (a primary diabetes treatment target) does not improve morbidity or mortality outcomes, including the UK PDS, ROSIE trial, and ACCORD trial, indicating that A1C reduction is not a valid surrogate for metabolic improvementThe Subcellular Processes That Belie All Chronic Disease. The Hateful (or Grateful) Eight #lustig
- A continuous glucose monitor (CGM) is a subcutaneous device that measures interstitial glucose levels real-time by inserting a filament into the subcutaneous space, providing continuous feedback rather than the snapshot provided by hemoglobin A1C testing.Outlive: The Science and Art of Longevity — Dr. Peter Attia